In response to the recent Association of British Pharmaceutical Industry (ABPI) report, which showed a sharp decline (41%) in clinical trials initiated by the UK in the period 2017 to 2021,
A just-published report on the UK's life sciences sector "ought to ring alarm bells across government," according to the Association of the British Pharmaceutical Industry (ABPI).<
